WebSite > Nantong Huichuang Chemical Co.,Ltd

Nantong Huichuang Chemical Co.,Ltd

  • Company Name Nantong Huichuang Chemical Co.,Ltd
  • Tel -
  • Email sales1@favorpharma.com.cn
  • WebSite www.favorpharma.com.cn
  • CB Index 58
  •       NANTONG HUICHUANG CHEMICAL CO., LTD.. was established in June2018. Our main business is CMO&CDMO; we serve new drug R&D companies all around the world to provide molecular cutting of new drugs, and provide commercial production ranging from 100g to ton level; At the same time, we develop,produce and sell technically difficult generic pharmaceutical intermediates that have been on the market. Owing to long-term cooperation with several GMP certified, GMP-based high-end factories and ISO certified multifunctional chemical factories, we have good ability to meet the quality declaration requirements of different customers. There is a young and outstanding management team with rich management experience and industry experience, as well as excellent quality such as guidance, affinity, and execution. Every manager will do his best to contribute to the development of our company to our customers. Through working closely with pharmaceutical product suppliers and research and development units of pharmaceutical technology, we are committed to the research and development of APIs and pharmaceutical intermediates with high synthetic technical barriers, difficulty, and high added-values. We alsofocus on the synthesis of chiral compounds. We take pharmaceutical research and development as our business, and take customer needs as our responsibility. A strong R&D team and professional and high-level technical services are our guarantee toour customers.
Nantong Huichuang Chemical Co.,Ltd Product List
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Product Name LUMAT-005
  • MF C16H19N3O3
  • CAS 313369-16-3
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •